As healthcare professionals, we encounter pyrexia, or fever, regularly in clinical practice. Despite its common occurrence, its management can be complex, necessitating a comprehensive understanding of its etiology, pathophysiology, and treatment options.
Pyrexia is a physiological response to various conditions, most commonly infections. It results from the release of pyrogens, which reset the hypothalamic temperature set-point, leading to increased body temperature. Understanding the underlying cause is crucial in managing pyrexia effectively.
Assessment of the febrile patient should include a thorough history and physical examination. Key factors to consider are the duration and pattern of the fever, associated symptoms, and potential exposure to infectious agents. Laboratory investigations, such as complete blood count, inflammatory markers, and cultures, can provide valuable information.
Treatment of pyrexia primarily focuses on addressing the underlying cause. In cases of infection, appropriate antibiotics should be administered. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs, can be used to alleviate discomfort but should not replace the treatment of the underlying cause. In some cases, pyrexia can be a helpful physiological response, enhancing immune function and inhibiting pathogen growth.
Special considerations should be given to immunocompromised patients, as their fevers may indicate serious infections. Elderly patients may present atypically, with confusion or falls instead of fever. In neonates, pyrexia may be the only sign of serious bacterial infection and warrants immediate investigation.
In conclusion, managing pyrexia in clinical practice requires a comprehensive approach, understanding its etiology, conducting a thorough assessment, and implementing appropriate treatment. Special attention should be given to vulnerable populations. As healthcare professionals, our role is not just to treat the fever, but to understand and address its underlying cause.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation